Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.

"Declarations Ethics statementThe studies involving human participants were reviewed and approved by relevant institutional review board or ethics committee at each trial site. The patients/participants provided their written informed consent to participate in this study. Conflict of interestVip Viprakasit received research funds and advisory board compensation from Novartis Pharma AG, F. Hoffman-La Roche, Bristol Myers Squibb, Agios, Silence, Ionis Pharmaceuticals, Thermo Fisher Scientific, Qiagen, Roche Diagnostics, and Sebia. Mona M. Hamdy, Hoda M.A. Hassab and Suporn Chuncharunee are Principal Investigators in this phase 2 study and received research grants from Novartis Pharmaceuticals. Ali T. Taher received research grants and consulting fees from Novartis Pharmaceuticals, Bristol Myers Squibb (Celgene), Vifor, Pharmacosmos, and Agios. Ankita Shekhawat, Yamini Sonawane, Laura Torres Perez, and Cassandra Slader are employed by Novartis. Novartis Pharma AG supported the development of this manuscript, provided data analyses according to the direction of the authors, and paid for medical writing support. All authors declare no other competing interests related to the study. Conflict of interest Vip Viprakasit received research funds and advisory board compensation from Novartis Pharma AG, F. Hoffman-La Roche, Bristol Myers Squibb, Agios, Silence, Ionis Pharmaceuticals, Thermo Fisher Scientific, Qiagen, Roche Diagnostics, and Sebia. Mona M. Hamdy, Hoda M.A. Hassab and Suporn Chuncharunee are Principal Investigators in this phase 2 study and received research grants from Novartis Pharmaceuticals. Ali T. Taher received research grants and consulting fees from Novartis Pharmaceuticals, Bristol Myers Squibb (Celgene), Vifor, Pharmacosmos, and Agios. Ankita Shekhawat, Yamini Sonawane, Laura Torres Perez, and Cassandra Slader are employed by Novartis. Novartis Pharma AG supported the development of this manuscript, provided data analyses according to the direction of the authors, and paid for medical writing support. All authors declare no other competing interests related to the study."

"Funding This study was funded by Novartis Pharma AG, Basel, Switzerland. Novartis Pharma AG supported the development of this manuscript, provided data analyses according to the direction of the authors and paid for medical writing support."